Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |